Be Biopharma Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 51-100 Employees

Be Biopharma revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$61,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,000,000
Total funding	$304,000,000

Key Contacts at Be Biopharma

Anja Hohmann

Senior Director, Cell Engineering

Joanne Smith-Farrell

Chief Executive Officer

Alan Gilbert

Senior Director

Bryan Chin

Associate Director Clinical Operations

Sean Marnane

Senior Director, External Manufacturing And Msat

Liana R Juarez

Associate Director, Laboratory Operations & Vendor Management

Mark Lalli

Director, Process Development

Rex Ready

Senior Director Quality Assurance

Kevin Moran

Director Regulatory Affairs

Sean Arlauckas

Senior Director, B Cell Platform

Company overview

Headquarters	One Kendall Square, Building 200, Floor 3, Cambridge, Massachusetts 02139, US
Websites	be.bio bebiopharma.com
Founded	2020
Employees	51-100
Socials

Be Biopharma Email Formats

Be Biopharma uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@be.bio), used 98.3% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@be.bio	98.3%
{first initial}{last name}	jdoe@be.bio	1.7%

About Be Biopharma

Be Bio is pioneering Engineered B Cell Medicines (BCMs) to dramatically improve the lives of patients who are living with Hemophilia B and other genetic diseases, cancer, and other serious conditions. With eyes locked on the patient, our team of purpose-driven scientists, technologists, manufacturing experts and business builders collaborate to create a bold new class of cell therapies.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Senior

Director

Employees by Department

Be Biopharma has 35 employees across 12 departments.

Departments

Number of employees

Funding Data

Explore Be Biopharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2022-05-14	5	$130,000,000
2024-11-22	1	$82,000,000
2025-02-15	6	$92,000,000

Funding Insights

$304,000,000

Total funding amount

$92,000,000

Most recent funding amount

Number of funding rounds

Be Biopharma Tech Stack

Discover the technologies and tools that power Be Biopharma's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Cloudflare Bot Management

Security

Slick

JavaScript libraries

Vimeo

Video players

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

Elementor

Page builders

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

Genesis theme

WordPress themes

jQuery

JavaScript libraries

Frequently asked questions

Be Biopharma is located in Cambridge, Massachusetts, US.

Be Biopharma generates an estimated annual revenue of $5,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Be Biopharma has an estimated valuation of $16,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Be Biopharma was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Be Biopharma has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Be Biopharma has raised a total of $304,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Be Biopharma

Anja Hohmann

Senior Director, Cell Engineering

Joanne Smith-Farrell

Chief Executive Officer

Alan Gilbert

Senior Director

Bryan Chin

Associate Director Clinical Operations

Sean Marnane